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PROCAAINE, administered intravenouisly, P exerts an antiarrhythmic action on the heart.' Hlowever, its stimulatory effects on the central nervous system limit its application ais an ainitiarrihvthmic drug to the anesthetized patient. In addition, procaine is rapidly inactivate(l by its hydrolysis in the blood stream to p-aminobenzoic acid and diethylaminoethanol. The latter compound in rather large (losage also exhibits antiarrhythmic action, but with minimal stimulatory effects on the central nervous system. In a previous communication, experiences with diethylaminoethanol and its possible value in ventricular tachycardia were discussed .' A series of derivatives of diethylaminoethanol were synthesized* in the hope that the activitv of the alcohol could be enhanced without a comparal)le increase in toxicity and that a (ompoundi would be found which wouldl have greater stability than procaine. The compounds From the Third (New York University) Medical aindl Research Services, Goldwater XIemorial Hospital, Welfare Island, N. Y., and the Department of Aniesthesiology, New York University -Bellevue Medical Center, New York, N. Y., and the National lheart Institute, National Institutes of llealth, Bethesda, Mld.
A preliminary report of this study was )resented att the annual meeting of the American Ileart Association, June, 1950. During the course of this work, one of us (L. C. M.) was a Research Fellow of the American Heart Association. * were tested for antiarrhythmic activity on1 the ventricular tachycardia which is induced by injection of epinephrine into dogs anesthetized with cyclopropane. The most promising compound of the series was procaine amide,t the amide analogue of procaine. This report is concerned with results obtained in treating v-arious cardiac arrhythmias wvith procaine amide. The pharmacologic data on procaine amide has been detailed elsewhere.3 Briefly, the drug is rapidly and completely absorbed from the gastrointestinal tract, peak blood concentrations being obtained one to two hours after its oral administration. It is relatively stable in the body, not being affected by the enzyme which catalyzes the hydrolysis of procaine. It is slowly excreted by the kidneys, plasma levels declining only, about 15 per cent per hour. About 60 per cent of the (Irug is excreted unchanged in the urine. In patients with normal renal function, plasma levels reach a relative plateau after 36 to 48 hours of repeated oral administration of a constant amount.
The most common arrhythmia available for study was the premature contraction of ventricular origin. The effects of procaine amide were observed in 54 patients with this condition. In some patients, the premature beats were attributable to the administration of digitalis, while in others they were associated with organic, primarily arteriosclerotic heart disease.
In each instance, the drug administered orally or intravenously in doses varying from 0.4 to 1.0 Gm., suppressed the ectopic beats. On intravenous administration the effect occurred (luring or shortly following the period of injection; after oral administration there was usually a delay of 30 to 60 minutes. After a single intravenous dose, the period of suppression usually varied from three to six hours. The irregularity of the occurrence of extra-one patient, therapy has been continued successfully for four months.
The effect of procaine amide on ventricular tachycardia was studied in 15 patients with this disturbance. In 13 of these, administration of the drug orally, intravenously, or by both routes was successful in that there was reversion to the cardiac rhythm that existed prior to the ventricular tachycardia. (Three examples are shown in figures 1, 2 and 3.) There were two
Effect of procaine amide on ventricular tachycardia (case 5). Al, lead I; B, lead II, and C, lead III: control tracings. Ventricular tachycardia. Rate 190 per minute. D. After injection 600 mg. procaine amide (lead II). E. After injection 1 Gm. procaine amide (lead II). Maintenance oral therapy 1 Gm. every three hours (see case report). F. Four hours later (lead I). Ventricular tachycardia recurred. Dosage increased to 1 Gm. every two hours. G, lead I; H, lead II; and 1, lead III: 12 hours later. Normal sinus rhythm. Rate 78. systoles makes it difficult, however, to estimate the duration of effect of the drug. In an occasional patient suppression has lasted for less than one hour, and in a few for more than 24 hours. Experience with oral administration has helped in estimating the duration of effect. Following a single oral dose, the usual period of suppression appeared to be the same as with an intravenous dose, namely three to six hours. In 14 cases, the administration of procaine amide at intervals of three to six hours successfully prevented the recurrence of ventricular extrasystoles for many weeks. In failures. One patient (case 3), who presented an unusually difficult problem, died during intravenous injection of procaine amide. In retrospect, too rapid administration of the drug may have been responsible for the development of ventricular fibrillation. In the other patient (case 9), death due to ventricular fibrillation occurred during administration of procaine amide, but before a significant quantity (150 mg.) had been administered. A resume of the clinical findings and therapy for each of the treated cases is appended.
Analysis of the electrocardiograms obtained during intravenous injections indicates that the sequence of events incidental to the interruption of ventricular tachycardia may vary considerably. In some cases, the ventricular tachycardia is abruptly interrupted and a supiaventricular pacemaker, frequently the A-V inode, is established. This occurs with or without preliminary slowing of the ventricular rate. In other patients, the aberrant rhythm does
Apparently the duration of the abnormal rhythm is of considerable importance. Ten patients with chronic auricular flutter and 14 patients with chronic auricular fibrillation were treated with 1 Gm. of procaine amide injected intravenously over a period of five minutes. In none of these patients was normal sinus rhythm reestablished, but an effect on auricular activity was observed in that there was marked not terminate abruptly; occasional beats of supraventricular origin first interrupt the ventricular tachycardia, increase in frequency during a period of several minutes, until the supraventricular pacemaker is established. The course of response is not predictable. The treatment of patients with auricular arrhythmias was much less successful. Auricular premature contractions could be eliminated by intravenous administration of procaine amide, but the effect was of shorter duration than with ventricular premature contractions.
slowing of the f waves ( fig. 4 ). In 2 patients with recently established auricular fibrillation, however, normal rhythm appeared during the intravenous administration of 1 Gm. of procaine amide and persisted for several days. Further exploration of the effect of the drug on auricular fibrillation of recent origin seems warranted.
Two patients with nodal tachycardia were treated with procaine amide. One patient reverted to normal rhythm once on oral administration (3 Gm. in 5 ). The other patient did not respond to 1 Gm. given intravenously. This patient was not treated further with the drug. The mechanism of action of procaine amide is not completely understood. The refractory period, as measured by Q-T interval, is prolonged and conduction is apparently slowed. In animal studies, procaine amide has been shown to increase the threshold to electrical stimulation of the ventricle.2 patients receiving a single dose, but may persist in patients on oral maintenance therapy. The development of ectopic beats as a result of the injection of procaine amide has not been observed. Administration of procaine amide to patients who already had signs of digitalis or quinidine toxicity did not result in untoward reactions.
Toxic effects have been limited to the circulatory and gastrointestinal systems. Anorexia, nausea, and vomiting were present only on high Electrocardiographic changes were noted in approximately one-third of patients receiving procaine amide orally or intravenously.* They have consisted in widening of QRS and Q-T intervals and diminution of voltage of QRS and T waves. The changes are transient in observed with oral administration even in the nine bouts of ventricular tachycardia successfully treated by this route.
Any dosage schedule based on the limited number of cases so far studied is, naturally, a provisional one. The intravenous route is preferable only in patients who are critically ill or who are unable to take oral medication. The maximal rate of intravenous administration has been 200 mg. per minute until aberrant rhythm has been interrupted or until a total of 1 Gm. has been administered. It is helpful to have an electrocardiogram, preferably recorded with a direct-writing instrument, during the injection. Because blood pressure often falls, it also should be freutiently recorded. When the drug is given orally to patients, 1.25 Gm. may be given initially, and if the electrocar(Iiogram reveals no change in one hour, a seconI (lose of 0.75 Gm. Further doses of 0.5 to 1 Gm. may, be administered every two hours as re(luired until the aberrant rhythm is eliminatedl. Maintenance oral therapy may be necessary to prevent recurrence of extrasystoles and paroxysms of ventricular tachycardia. D)oses of 0.5 to 1 Glm. administered every three to six hours during the day and night have maintained normal rhythm in patients studied to date. Similar oral schedules are iecommencledl for ventricular premature contractions -iequirements have varied from 1.5 to 8 Gm. per day in divided doses. Since the drug is excreted to a large extent by the kidneys, patients with impaired renal function receiving oral maintenance therapy may achieve unusually high plasma levels. Further investigation is needed to evaluate the place of procaine amide in the treatment of cardiac arrhythmias. It would appear to be a safer and more effective agent than (uinidine in the management of ventricular tachycardia and Ventricular extrasystoles. Its application to the control of archhvthmias in anesthesia and in cardiac surgery is at present under study. Initial reports indicate that the prophylactic administration of procaine amide materially diminishes the incidence of arrhythmias during intrathoracic surgery.5 developed ventricular tachycardia. During the next 48 hours he was treated with quinidine sulfate orally to toxicity and magnesium sulfate intravenously, but there was no change in the rhythm. Then 0.5 Gm. of procaine amide w-as injected. At the end of injection (five minutes), occasional beats of sinus origin appeared, but the dominant rhythm remained that of ventricular tachvcardia. Twenty minutes later, 0.5 Gm. of procaine amide was again given intravenously, and resulted in the appearance of more beats of sinus origin, which, however, did not persist for long. In the succeeding 48 hours the intravenous injection of quinidine sulfate, atalbrine and diethylaminoethanol failed to interrupt the ventricular tachycardia. On the fifth day of the sust ained ventricular tachycardia, procaine amide was again tried intravenously. One Gm. given over a 10 minute period had no demonstrable effect; 35 minutes later a second dose of 1 Gm. administered over a five minute period produced frequent sinus beats that established trigeminy. An additional dose of 0.25 Gm. intravenously was given 20 minutes later. The ventricular premature contractions disappeared completely in 40 minutes and the patient had an entirely uneventful hospital convalescence. He was hospitalized again 18 months later because of congestive heart failure. He responded promptly to treatment and was discharged two weeks after admission.
Case 3. S. L., a 45 year old male, was admitted to the hospital with a history of sudden chest pain and palpitation. Two years previously he had sustained a my-ocardial infaretion. During the year p1rior to the second admission, he had observed increasing angina on effort. On admission, an electrocardiogram revealed ventricular tachycardia. Oral and intravenous therapy with quinidine administered to toxicity, as well as intravenous magnesium sulfate, did not alter the rhythm. On the third hospital day, 1 Gm. procaine amide administered intravenously in five minutes had no effect. An additional Cm. 30 minutes later produced occasional sinus beats (one per six to seven ventricular beats) for about 25 minutes. A third dose of 1 Gm. in three and a half minutes had no effect. That night 0.6 Gm. quinidine lactate was given intravenously without producing either toxic or therapeutic effect. The next (lay the patient appeared moribund. An attempt was made to give 2 Gm. procaine amide at a faster rate, that is 400 mg. per minute. After the injection of 1 Gm. in two and a half minutes (one half contemplated dose), the patient developed ventricular fibrillation and died. At autopsy extensive sclerosis of the coronary arteries was found. There was complete occlusion of left coronary artery and a recent thrombus in right coronary artery with fresh necrosis in the papillary muscle of left ventricle. The entire wall of the left ventricle was thin and fibrotic, and at the apex there was an area of calcification. Case 4. Wr. MI., a 52 year old white male office worker, was admitted to the hospital following collapse on the street. He had been admitted three years before with a diagnosis of myocardial infarction. During the year 1)110 to secon(l admission he had noted polv uria, anlld had lost (60 pounds. During the weeks just prior to aadmission, the patient complained of anorexia with nausea and vomiting, polydypsia and increasing retrosternal pain on mo(lerate effort. Examination on admission showed an acutely ill, pallid, apprehensive male; his blood pressure was 100/80 an(l his apical rate was 144 per minute. Examination of the urine showed a specific gravity of 1.032, 4 plus glycosuria and 2 plus acetonuria. After 12 hours of vigorous treatment with insulin and approplriate fluids, the urine became free of glucose and ketone bodies. During this period he was also digitalized with 1.2 mg. of digitoxin because of signs of congestive heart failure. An electrocardiogram taken at the end of this p)eriod of therapy revealed ventricular tachycardia. Oral quinidine was administered to toxicity. He was able to tolerate 3 Gm. daily in dlividedl doses for the first five days, and then only 1.5 Gm. daily in divided doses for second five (lays. No effect on the rhythm was noted, though the QRS interval widened considerably. On the eleventh hospital (lay procaine amide was given intravenously; at the end of three and a half minutes (642 mg.), the aberrant rhythm was abruptly terminated, and normal sinus rhythm reestablished. The patient had an entirely uneventful convalescence and was discharged at the end of six weeks.
Case 5. E. F., a 65 year ol0( white woman, was known to have had hypertension and diabetes mellitus for the prior 10 years. She was admitted to the hospital with a history of increasing dyspnea on effort and nocturnal orthopnea for two weeks and severe right upper quadrant pain for 24 hours. Physical examination showed an obese cyanotic female, in marked respiratory distress. Pulse rate was 90; blood pressure, 160/90. Examination of the lungs revealed many moist rales bilaterally; there was moderate distention of veins in the neck and a large tender liver extending 4 fingerbreadths below costal margin. Venous pressure was 200 mm. citrate and Decholin circulation time was 35 seconds. An electrocardiogram showed a rate of 90 per minute and changes consistent with posterior wall myocardial infarction. Oxygen, anticoagulants, penicillin is and digitalis (0.8 mg. digitoxin by mouth in six hours) were administered. The following morning the patient had developed a rapid cardiac rate of 200 per minute, which was shown by electrocardiogram to be ventricular tachycardia ( fig. 1A, B , C).
The attempted oral administration of 0.9 Gm. of quinidine was unsuccessful because of vomiting. Quinidine lactate, 0.65 Gm., was given intravenously in 250 cc. solution over a period of 75 minutes, and resulted in slowing of the rate from 170 to 140. Three and a half hours later, the administration of 1.4 Gm. procaine amide intravenously in divided doses over 30 minutes, established bigeminal and then trigeminal rhythm ( fig. ID, E) . Oral therapy of 1 Gm. every three hours was started, but after the second dose, ventricular tachycardia recurred (fig. IF) . The dosage schedule was increased to 1 Gm. every two hours, and 12 hours later an electrocardiogram showed normal sinus rhythm at a rate of 72 (fig. iG, H, I). Dosage was then reduced to 1 Gm. every three hours and the patient maintained normal sinus rihvthm. The blood pressure which had been about 90/60 during her tachvcardia, rose to 130/80. Twelve hours later the patient suddenly became very (IysJlneic and expired almost immediately. Permission for postmortem examination was refused.
Case 6. C.O., a 70 year old white female, was known to have had hypertension for 20 years. She had been bedridden for the past 10 years following a left hemiplegia. There was no history of cardiac decompensation. Electrocardiograms obtained during these 10 years of hospitalization had revealed normal sinus rhythm with wandering pacemaker and occasional ventricular premature contractions.
Suddenly, on Jan. 9, 1950, she noticed severe palpitation and an electrocardiogram showed y-entricular tachvcardia at a rate of 200 l)er minute. Procaine amide was given intravenously; after 200 mg. had been injected, beats of supraventricular origin aappeared. At the end of the injection of l Gm., the ectopic ventricular beats hadldisappeared and the pacemaker appeared to be located in the auriculoventricular node. The electrocardiogram at the termination of injection, showed changes suggestive of fresh mvocardial injury, but dulring the next four hours these abnormalities disappeared an(l normal sinus rhythm was established. An electrocardiogram on the next day (1/10/50) showted occasional ventricularl premature contractions and bursts of ventricular tachycardia. The oral administration of 1 Gm. procaine amide every three hours eliminated these irregularities and the medication was discontinued after five doses. Thirty-eight hours later (1/12/50) ventricular tachvcardia recurred. The oral administration of 1.5 Gm. procaine amide established normal sinus rhythm in 45 minutes. Oral maintenance therapy, 1 Gm. every four hours, was continued for four days and during this interval the patient had no aberrant beats. Medication was then discontinued. Three weeks later the patient once again complained of palpitation and an electrocardiogram again showed that ventricular tachycardia had recurred ( fig. 2A ). Procaine amide was given intravenously and at the end of 200 mg. supraventricular beats were observed to interrupt the ventricular rhythm, and after a total of 400 mg. the ectopic ventricular beats disappeared ( fig.  2B, C) . The rhythm again became nodal in origin for about two hours and then became normal sinus. An oral maintenance dose of 0 5 Gm. every four hours was given for five months, and during this period the patient remained in normal rhythm. At the end of this period, the medication was discontinued and during the succeeding 10 months there has been no recurrence of the abnormal rhythm.
Case 7. E. R., a 54 year old white male, was admitted on Dec. 25, 1949 with a history of angina on effort for 3 weeks and sudden severe sticking substernal pain for 24 hours prior to admission. There was no history of any previous cardiovascular (lisease. Physical examination showed a temperature of 101 F.; pulse rate, 96; and blood pressure, 110/80; the patient was not in acute distress and there were no signs of congestive heart failure. Heart sounds were of good quality; no thrills or murmurs were noted. The electrocardiogram showed normal sinus rhythm and changes indicative of acute infarction of the anterior wall of the heart. Therapy included oxygen, sedation, anticoagulants and quinidine, 0.4 Gm. every four hours, as a prophylactic measure. Eight days later (1/2/50), after an entirely uneventful course, the quinidine was discontinued. It was instituted again 24 hours later (1/3/50), when the patient had many ventricular premature contractions (0.4 Gm. administered every four hours four times). The next day (1/4/50), sustained ventricular tachycardia was present and the quinidine was increased to 0.65 Gm. every two hours to a total of 8 Gm. a day. The next day (1/5/50), there was a temporary establishment of normal sinus rhythm but the aberrant rhythm reappeared on 16/50 an(l continued uninterrupted for six days despite daily dosage of 8 Gm. of quinidine. On 1/12/50. a total of 1.5 Gm. of procaine amide was administered intravenously in two (loses 35 minutes apart without altering the rhythm. One half hour later an oral (lose of 1.5 Gm. was given, and two hours later an additional Gm. was given. An electrocardiogram taken one half hour after the second dose showed that normal sinus rhythm was present. He remained on a maintenance dose of procaine amide, 1 Gm. every four hours (six doses daily) for four days, without any aberrant beats being observed. Medication was then discontinued and the patient had an uneventful convalescence from the myocardial infarction.
Case 8. H. F., a 78 year old white male, was admitted to the hospital on Feb. 6, 1950 with a history of nausea, vomiting and precordial pain for one week. He had been hospitalized previously in 1947 because of anterior *vall infarction, and again in MIarch 1948 because of thrombophlebitis and pulmonarv infarction. In October 1948 he ha(1 again been hospitalized because of precordial pain, nausea and vomiting. During four weeks of ol)servation the findings were insufficient to establish the (liagnosis of fresh mnvocardial infarction. Diagnosis on (lischarge was arteriosclerotic heart disease, coronary insufficiencv .and aneurysm of the left xventricle. For the four months prior to the last adllission, the patient continued to receive digitalis an(l mercurial diuretics for his congestive heart failure. On admission, an electrocardiogram showed a venitricular tachv-carldia at a rate of 1 50 (fig.   3A , B, C, D). Quinidine sulfate, 0.2 Gm. orally ev-ery hourI for sixteen doses (3.2 Gm.), had no effect on the rhythm. On 2/8/50 1 Gm. of lrocaine amide was given intravenously in five minutes, and (lirectly after completion of the injection the ventricular tachvcardia was ab)rulptly terminate(l wvith the establishment of a supraventricular rlh-thm; the pacemaker was located at first in the auriculovrentricular. no(le, an(l then in the sinoauricular ( fig. 3E, F, G, II) . He was given 1 Gm. procaine amide orally every four hours for maintenance therapy but could not tolerate this (lose because of nausea. The drug was therefore discontinue(l after two (lays. One week later paroxysmal ventricular tachyl-cad(lia reappeared. He was given lprocaine ami(le orally 1 Gm. every hour and after the second (lose was in normal sinus rlhythm. Maintenance therapy-(4 Gm. a day) was successfully continued for five weeks. Clinical findings and serial electrocar(liograms confirmed the impression of fresh mvocar(lial infaretion. Iatient was (lischarge(l after a lengthy hospitalization.
Case 9. J. B. was a 61 year o0l white male with a hiistory of ( ongestive heart failure controlled bv (ligitalis and mercurial (liuretics for two years. Though he gave no history of rheumatic fever, he had evidence of valvular (leformities of both the mitral and aortic valves. Electrocardiograms in this lerio(I had revealed auricultar fibrillation. On 3/8/50 (ligitalis mnelication was (liscontinue(l anll in the next 10 (lays the l)atient gainecl 14 pounds and went rapi(lly into acute (ongestive heart failure. \Vhen examined on 3/18/50, he exhibited signs of pulmnonary edema anlid a very rapid apical rate. An electrocardiogram showed the presence of ventricular tachvcardia. After receiving 200 mg. procaine amide intravenously the ventricular rlhythn cease(l and auricular fibrillation with a ventricular iate of 130 supervened. The rhythm remained unchanged for the next 30 minutes. At the end of this perio(l 0.8 mg. lanatoside C was given intravenously in 10 minutes. An electrocardiogram at the end of this injection again revealed ventricular tachvcardia. Procaine ami(le therapy intravenously was again started but by the tune that 150 inlg. were injecte(l, the lhythlm changed to ventricular fibrillation anl the patient expired. Postmortem examination revealed extensive rheumatic involvement of the aor.
tic, mitral and tricuspid valves. An area of fresh pulmnonarv infarction was found in the left lung.
Case 10. J. W., a 60 vear old white male, was known to have had hypertension for eight years OIn Jan. 2, 1950 lie was hospitalized because of severe l)recordial pain. Clinical and electrocardiograp)liic findings substantiated the diagnosis of acute myocardial infarction. His course during three months of hospitalization an(l convalescence was entirelv uneventful. One week afterldischarge, the patient noted increasing dlyspnea on exertion ami(l ankle edema. A maintenance dose of digitalis was prescribed andlduring the next week there was gradual improvement in the l)atient's condition. Suddenly, on the eighth (lay, the l)atient noted palpitation and weakness. Examination revealed a very rapid cardiac rate, and the patient was hos-
pitalized. An electrocardiogram showed a ventricular tachvcardia at a rate of 200. He was given 1 Gm. of l)rocaine amide intravenously in divided doses, with the establishment of a nodal rhythm. Subsequent electrocardiograms and clinical findings indicated fresh mvocardial damaoe. Ten days later (5/15/50), the patient again (levelopeil ventricular tachy-cairdia during (lefecation. On this occasion 400 mg. l)rocaine amide injected intravenously restorecl normal rhythm. During the succeeding six months of hospitalization the patient had six bouts of ventricular tachycardia, each of which was termiinated bv procaine ainide, administered orally, intravenously or by both routes. Four of these bouts appeared to be precipitated bythe use of various digitalis glycosides given because of appearance of signs of congestive heart failure. Two of these bouts occurred despite a high maintenance (lose (6 Gm. a (lay) of procaine amidle orally. At l)resent (12/11/50), the patient is satisfactorily maintained on this oral maintenance (lose, and his congestive heart failure is controlled by diet and mercurial diuretics.
Case 11. S. F. a 60 year old white male, was first admitted to the hospital on Jan. 21, 1950 complaining of left-sided chest pain. He had been treated for thrombophlebitis of the left leg which had developecl five (lays prior to admission. He was hospitalized for pulmonary infarction. Subsequently, both clinical and laboratory findings indlicatedl hepatitis which prolonged his stay in hospital for two months. He was discharged oil 3/15/50. Two months later he was again hospitalized because of recurrent pulmonary infarction. On admission, an electrocardiogram showed ventricular tachycardia. He was given 1 Gm. I)rocaine tachvcardlia ceased. The initial rhythlnm established after interruption of the tachycardia w-as idioventricular with complete auriculoventricular dissociat ion; subsequently normal sinus rhlythm appeared. Evidence of fresh myocardial damage was lacking and the patient was discharged two weeks later. Case 13. MI. F., a 70 vear old l-hite wvoman, was hospitalized since 1947 because of a left hlemiplegia and aphasia. On March 22, 1950 the patient complainecl of difficulty in voiding ani1d was given 1 cc. of prostigmine (1:2000) subcutanieouslyN. One hour later her blood pressure fell to 80/60 and the patient became cold and vomited. An electrocardiogra.m revealed ventricular tachycardia. The intravenous administration of 0.5 mIg. of ouabain had no effect on the rhythm. One hour later the intravenous administration of 500 mIg. of procaine ami(le promptly restore(1 normal sinus rihythlii. There has been no subsequent change in her clinicl. status.
Case 14. E. P., a 70 yeal old whllite womn.ll with a history of hypertension for fire years an(l *liabetes mellitus for eight months, was hospitalized in 1949 for an acute myocardial infarction. She was admittecl to the hospital again onl Aug. 22, 1950 because of severe dy-slpnen. It was difficult to obtain an accurate history, but the patient had received (ligitalis (0.1 Gm.) for 10 (lays l)rior to a(lmission because of increasing (Iysi)nea and edlema. On admission an electrocardiogranm showed ventricular tachycardia. She was given 0.25 GI1. l)rocaine amide intravenously without effect, but the second injection of the same amount 30 minutes later was followed by a change in rhythm to that of auricular fibrillation with lremature ventricular contractions.
Oral l)rocaine amide was given, 0.25 Gm. everv four hours. The patient w-as digitalizedl over the next 24 hours and the ventricular rate slowed to 112, htut the auricles continued to fibrillate. Six hours later the patient spontaneously reverted to normal sinus rhythm. Digitalis and procaine aminie w-ere discontinuecl. Dvspnea disappeared and no other signs of congestive failure occurl'e(l (lturing her convalescence.
Case 15. 1). L., a 53 year ol(1 white wonian wsitlh a history of extensive rheumiatoid arthritis for 10 yeairs, was hospitalized in September 1949 hecautse of exacerbation of her arthritis. For five and a half months her clinical course wats uneventful; on1 3/2/50 her temperature rose su(l(lenlv to 1 04 F. a)]pparentl (lue to an ischilorectal abscess. The heairt rate wvas found to be ral)i ( (136) and an electrocardiogrlai revealed ventricular tachycardia. Quini-(line byv mouth for the next two (lays temporarilv interrupte(l the taclhv cardiai, but the patient became unable to tolerate further. medication with quini(line.
On the evening of 3/4/50, the injection of 0.5 Gm. of procaine amidle intravenously was immediately followed. by cessation of the ventricular tachycardia annl oral maintenance therapy was startenl at this tinie. On the next day, the 1)atient had two bouts of v-entricular tchcardia, ea(h controlled by1 an a((l itional (lose of l Gm. p)rocaine ainide orally.
For the next 10 clays, the I)atient received between 8 and. 12 Gm. orally each (lay and maintainecl normal sintus rhythm with occasional plremature ventricular contractions. The daily (lose of 12 Gm. appeared to be toxic as evidenced by anorexia, nausea, vomiting and mental confusion. On 3/14/50, the patient .again became febrile without obvious explanation and the procaine amide was discontinued. The fever persisted and the patient's condlition dleteriorated rapidly; she dlied on 3/17/50. There were no rhy-thmic abnormalities (luring the last three days of her life. Postmortem examination revealed ol0( rheumatoid arthritis, extensive (liffuse fibrinous pericarditis, and areas of collagen necrosis in the mvocardium.
1. Procaine amide, an analogue of procaine, has been found to be effective in treaCting arrhythmias of ventricular origin.
2. In 54 patients with premature ventrieutlar contractions procaine amide andministered orally or intravenously effectively suppressed the aberrant beats.
3. In 13 of 15 patients with ventni ular tachycardia, the abnormal rhythm was, terminated by intravenous or oral administration of procaine amide. Six had previously been treated wN-ith quinidine to toxicity without success. 4. Oral rather than intravenous administration is preferable, unless the patient is comatose or vomiting. 5. Procaine amide did not establish normal rhythm in 24 patients with chronic auricular flutter and fibrillation. In 2 cases of recent auricular fibrillation, normal sinus rhythm followed the use of the drug.
